Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial
β Scribed by Robert L. Grubb III; Paul F. Pinsky; Robert T. Greenlee; Grant Izmirlian; Anthony B. Miller; Thomas P. Hickey; Thomas L. Riley; Jerome E. Mabie; David L. Levin; David Chia; Barnett S. Kramer; Douglas J. Reding; Timothy R. Church; Lance A. Yokochi; Paul A. Kvale; Joel L. Weissfeld; Donald A. Urban; Saundra S. Buys; Edward P. Gelmann; Lawrence R. Ragard; E. David Crawford; Philip C. Prorok; John K. Gohagan; Christine D. Berg; Gerald L. Andriole
- Book ID
- 109055509
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 186 KB
- Volume
- 102
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Two largeβscale randomized screening trials, the Prostate, Lung, Colorectal and Ovary (PLCO) cancer trial in the USA and the European Randomized Screening for Prostate Cancer (ERSPC) trial in Europe are currently under way, aimed at assessing whether screening reduces prostate cancer mo
The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female